Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... based rescue medicine to be cleared ...

for patients with asthma and chronic obstructive pulmonary disease (COPD). Teva noted it is the first and only digital rescue inhaler indicated in patients four years or older for the treatment ...

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

Whether treating COPD or asthma, Trelegy Ellipta may help ease symptoms over time. The medication is not FDA approved as a rescue inhaler to relieve sudden breathing difficulties. A doctor can ...

Hospitalists work hard (not that we have to tell you that!), so celebrating March 6 as National Hospitalist Day is an ideal ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

Always have a rescue inhaler with you. Before you use Ohtuvayre ... the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory ...

COPD is a chronic (long-term ... Do not use Ohtuvayre to treat sudden breathing problems. Always have a rescue inhaler with you. Who Should Not use Ohtuvayre? Do not use Ohtuvayre if you have ...